Samtsov A V, Tarasenko G N, Smirnov A V
Voen Med Zh. 1998 May;319(5):50-4, 96.
At 51 men at the age from 20 till 30, sick with pyodermatitis, the clinical-immunological aspects and efficiency of-actoprotector, capable to support motor activity and human performance in the extreme environments. Bemitil has appeared more effective in comparison with conventional therapy: by general and combined application the parameters of immunity have been normalized statistically authentically, and at outside application-the places of damage were cleared faster, disappeared painfulness, hyperemia, edema, terms of staying in the hospital were reduced. The clinical recovery was in 86.3 +/- 4.8% of the patients, while effectiveness from conventional means was 62.1 +/- 6.8%.
对51名年龄在20至30岁之间患有脓皮病的男性患者，研究了actoprotector的临床免疫学方面及其在极端环境中支持运动活动和人体机能的效果。与传统疗法相比，贝米替尔似乎更有效：通过全身和联合应用，免疫参数在统计学上得到了显著正常化，而在局部应用时，损伤部位愈合更快，疼痛、充血、水肿消失，住院时间缩短。86.3±4.8%的患者实现了临床康复，而传统方法的有效率为62.1±6.8%。
